Top Vaccines companies in Netherlands by Revenue
This ranking features the top 5 Vaccines companies in Netherlands ranked by Revenue, totaling a Revenue of USD 1.29 B, for February 06, 2025.
Netherlands
Vaccines
Revenue
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.23 B
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
| 2 |
USD 43.95 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 3 |
USD 12.76 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 4 |
USD 6.77 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 5 |
USD 0.00
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
Frequently Asked Questions
-
Which Vaccines company in Netherlands has the highest Revenue ?
The Vaccines company in Netherlands with the highest Revenue is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 1.23 B.
-
Which Vaccines company in Netherlands has the lowest Revenue ?
The Vaccines company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.
-
What are the top 10 Vaccines companies in Netherlands by Revenue ?
The top 10 Vaccines companies in Netherlands by Revenue are argenx SE, Merus N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V. and Pharvaris N.V..
-
What are the bottom 10 Vaccines companies in Netherlands by Revenue ?
The bottom 10 Vaccines companies in Netherlands by Revenue are Pharvaris N.V., LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V., Merus N.V. and argenx SE.
